 BEDFORD, Mass.--BUSINESS WIRE--- OCUL OCUTX--Ocular Therapeutix, Inc. NASDAQ:OCUL, a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will participate in a fireside chat at the Cowen 42nd Annual Healthcare Conference on Wednesday, March 9, 2022 at 9:10 AM EDT In addition to the presentation, the managem 